BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21768514)

  • 21. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
    Mónico A; Nim S; Duarte N; Rawal MK; Prasad R; Di Pietro A; Ferreira MU
    Bioorg Med Chem; 2017 Jul; 25(13):3278-3284. PubMed ID: 28479022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA; Reis de Sá LF; Moraes DC; Soares RM; Ferreira-Pereira A
    J Mycol Med; 2018 Mar; 28(1):137-142. PubMed ID: 29217144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
    Zhang H; Gao A; Li F; Zhang G; Ho HI; Liao W
    Yakugaku Zasshi; 2009 May; 129(5):623-30. PubMed ID: 19420894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione.
    Zhu J; Krom BP; Sanglard D; Intapa C; Dawson CC; Peters BM; Shirtliff ME; Jabra-Rizk MA
    PLoS One; 2011; 6(12):e28830. PubMed ID: 22205973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor.
    Niimi K; Harding DR; Holmes AR; Lamping E; Niimi M; Tyndall JD; Cannon RD; Monk BC
    Mol Microbiol; 2012 Aug; 85(4):747-67. PubMed ID: 22788839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals.
    Jaiswal N; Kumar A
    Mol Biotechnol; 2024 May; 66(5):960-974. PubMed ID: 38206530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.
    Ivnitski-Steele I; Holmes AR; Lamping E; Monk BC; Cannon RD; Sklar LA
    Anal Biochem; 2009 Nov; 394(1):87-91. PubMed ID: 19577533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic interactions between β-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans.
    Moraes DC; Reis de Sá LF; Domingos LTS; Pinto MDCFR; Soares RMA; Ferreira-Pereira A
    Rev Iberoam Micol; 2020; 37(3-4):104-106. PubMed ID: 33229297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
    J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Learning the ABC of oral fungal drug resistance.
    Cannon RD; Holmes AR
    Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1.
    Gil F; Laiolo J; Bayona-Pacheco B; Cannon RD; Ferreira-Pereira A; Carpinella MC
    BMC Complement Med Ther; 2022 Oct; 22(1):264. PubMed ID: 36224581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Jatrophane Esters from Euphorbia spp. as Modulators of Candida albicans Multidrug Transporters.
    Esposito M; Nim S; Nothias LF; Gallard JF; Rawal MK; Costa J; Roussi F; Prasad R; Di Pietro A; Paolini J; Litaudon M
    J Nat Prod; 2017 Feb; 80(2):479-487. PubMed ID: 28106996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
    Tanabe K; Lamping E; Nagi M; Okawada A; Holmes AR; Miyazaki Y; Cannon RD; Monk BC; Niimi M
    Mol Microbiol; 2011 Oct; 82(2):416-33. PubMed ID: 21895791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
    Niimi M; Niimi K; Tanabe K; Cannon RD; Lamping E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0174821. PubMed ID: 34780272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain.
    de Moraes DC; Cardoso KM; Domingos LTS; do Carmo Freire Ribeiro Pinto M; Monteiro RQ; Ferreira-Pereira A
    Braz J Microbiol; 2020 Sep; 51(3):1051-1060. PubMed ID: 32157667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.